Armistice Capital »

Nexalin Technology shares owned by Armistice Capital

Quarter-by-quarter ownership of Nexalin Technology (NXLIW) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Nexalin Technology

Tip: Access up to 7 years of quarterly data

All positions including Nexalin Technology held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nexalin Technology by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $8.1k 325k 0.03
2023-06-30 $36k 325k 0.11
2023-03-31 $31k 325k 0.10
2022-12-31 $65k 325k 0.20
2022-09-30 $58k 325k 0.18

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Nexalin Technology

Warberg Asset Management
Citadel Advisors
UBS Group

View all funds holding Nexalin Technology